Prevention of venous thromboembolism
150 results
51 - 150
Enoxaparin better than aspirin for prevention of venous thromboembolism after total hip or knee arthroplasty
Neuromuscular electrical stimulation for the prevention of venous thromboembolism
Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction) - Statins for primary prevention of venous thromboembolism: Cochrane systematic review
- Statins for the primary prevention of venous thromboembolism
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Prevention of venous thromboembolism
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
- Deep vein thrombosis
- Air travel and illness
- Leg oedema
- Patients with initial unprovoked DVT or PE benefit from long-term low-dose aspirin (INSPIRE)
- Cast treatment of lower extremity fractures
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
- IPC safer and as effective as medical prophylaxis; much better than TEDS
- Rosuvastatin prevents DVT at very high cost
- Evaluation of thrombophilia
- Compression stockings unnecessary for inpatients who undergo elective surgery
- Aspirin is no different than other anticoagulants for VTE prevention after joint replacement surgery
- Benefits/harms of novel oral anticoagulants similar in general population and the elderly
- Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
- Mobile compression device = LMWH for DVT prevention after hip replacement, less bleeding
- Antithrombotic agents in primary health care
- Abelacimab prevents asymptomatic clots better than enoxaparin, but there is no difference in clinical clots or major bleeding
- Low molecular weight heparin in patients with lower-leg immobilization
- Stockings plus anticoagulation more effective to prevent post-op VTE, but anticoagulation increases bleeding
- Aspirin alone may be sufficient protection from postop VTE after total knee arthroplasty
- Acute treatment of traumatic spinal cord injuries
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
- Superficial venous thrombophlebitis
- Warfarin therapy
- Direct oral anticoagulants
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement: Cochrane systematic review
- Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
- Aspirin as safe and effective as LMWH for extended thromboprophylaxis after THA
- Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity
- Hormone therapy for preventing cardiovascular disease in post‐menopausal women
- Overweight in pregnancy
- Long‐term hormone therapy for perimenopausal and postmenopausal women
- Hormone therapy for preventing cardiovascular disease in post-menopausal women
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Semi‐recumbent position versus supine position for the prevention of ventilator‐associated pneumonia in adults requiring mechanical ventilation
- Temporary IVC filter added to anticoagulation does not decrease risk of PE recurrence
- Low-molecular-weight heparins vs. standard heparin for acute ischaemic stroke
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
- Lower leg fractures
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Methods for administering subcutaneous heparin during pregnancy
- Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
- Strontium ranelate for preventing and treating postmenopausal osteoporosis
- Graduated compression stockings for prevention of deep vein thrombosis
- Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- Menopausal symptoms and hormone therapy
- Thiazide diuretics and the risk of hip fracture: Cochrane systematic review
- Adder (Vipera berus) bite
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Anticoagulants for people hospitalised with COVID‐19
- Dopamine agonists for preventing ovarian hyperstimulation syndrome
- COVID-19 and other coronavirus infections